Health care is so expensive that 31 million U.S. adults, or 12%, had to borrow a total of $74 billion last year to obtain ...
Find insight on Merck KGaA, Bayer, Jazz Pharmaceuticals and the use of AI in China’s healthcare sector in the latest Market ...
Citi says a Texas Northern Court ruled yesterday against the Outsourcing Facilities Association’s preliminary injunction against the FDA ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Citi analyst Daniel Grosslight keeps a Sell rating on Hims & Hers (HIMS) with a $27 price target after Novo Nordisk (NVO) announced ...
Fintel reports that on March 5, 2025, Citigroup upgraded their outlook for ResMed (NYSE:RMD) from Neutral to Buy. Analyst ...